TMEM100 and colorectal cancer: The overexpression of TMEM100 shortens the half-life of hypoxia-inducible factor-1α (HIF-1α) via ubiquitination and the proteasome pathway and inhibits colorectal cancer cells’ migration and angiogenesis potential [42].